Breast Cancer Medicinal Breakthrough | ADHD Information
Cool find, Davido, but you're medical practice will now suffer b/c of it...
Tryan will have you do them at the same time now...
Source:
Mayo Clinic
Date:
2005-10-20
Print this page
Email to friend
In a joint paper, co-authored by Mayo Clinic's Edith Perez, M.D., and Edward Romond, M.D., of the National Surgical Adjuvant Breast and Bowel Project (NSABP), researchers report complete and combined results of two trials comparing adjuvant chemotherapy with or without concurrent trastuzumab treatment in women with surgically removed HER2-positive breast cancer. The studies showed trastuzumab (Herceptin®) therapy to be highly superior to standard treatment, reducing recurrence of cancer by half. The findings will be published in the Oct. 20, 2005, issue of The New England Journal of Medicine.
http://www.sciencedaily.com/releases/2005/10/051020090619.ht m